Superior Oral Bioavailability of Epigallocatechin Gallate from TèPigal 300®, a Dietary Supplement Versus a Cup of Green Tea

Background: Epigallocatechin Gallate (EGCG), a potent compound found in green tea, is renowned for its multifaceted health benefits. Unfortunately, despite its therapeutic potential, the bioavailability of EGCG remains a challenge and differences in bioavailability by mode of administration significantly influence its therapeutic efficacy. Oral intake of EGCG often results in low absorption due to factors such as first-pass metabolism and limited intestinal permeability. Our study focuses on TèPigal 300®, a product containing 300 mg of EGCG, comparing its plasma concentration profile to that of green tea. Methods and Findings: Through in-vitro dissolution studies, we observed a significant release of EGCG in alkaline pH conditions, closely mimicking the intestinal absorption environment, supporting the effectiveness of the tablet formulation in enhancing EGCG absorption. The clinical aspect of our research involved a study of 22 healthy subjects to evaluate the relative bioavailability of EGCG, based on plasma concentration profiles (AUC) of EGCG from one tablet of TèPigal 300® in comparison with the consumption of one cup of green tea. Notably, in 10 healthy subjects EGCG was detectable in the bloodstream within 15 minutes, with increasing levels up to 60 minutes. This pattern suggests efficient absorption following EGCG release. Further comparison with the consumption of 1 cup of green tea in 12 healthy subjects highlighted the superior oral bioavailability of EGCG from TèPigal 300® tablets over tea beverage intake, quantifying this difference as one TèPigal 300® tablet being equivalent to consuming 21 cups of green tea. Conclusion: our study underlines TèPigal 300® advantage in providing a more efficient convenient form of EGCG consumption, leading to potentially greater health benefits. Our promising results open avenues for future research on improving EGCG bioavailability through new technologies and nutrients synergies.

Authors

Publication Details

Journal
Journal of Clinical Medical Research
Published
2025-04-25
DOI
https://doi.org/10.46889/jcmr.2025.6111
Primary Topic
Tea Polyphenols and Effects
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Superior Oral Bioavailability of Epigallocatechin Gallate from TèPigal 300®, a Dietary Supplement Versus a Cup of Green Tea

Massimo Bonucci
Journal of Clinical Medical Research
Tea Polyphenols and Effects
article

Superior Oral Bioavailability of Epigallocatechin Gallate from TèPigal 300®, a Dietary Supplement Versus a Cup of Green Tea

Massimo Bonucci
article en

Abstract

Background: Epigallocatechin Gallate (EGCG), a potent compound found in green tea, is renowned for its multifaceted health benefits. Unfortunately, despite its therapeutic potential, the bioavailability of EGCG remains a challenge and differences in bioavailability by mode of administration significantly influence its therapeutic efficacy. Oral intake of EGCG often results in low absorption due to factors such as first-pass metabolism and limited intestinal permeability. Our study focuses on TèPigal 300®, a product containing 300 mg of EGCG, comparing its plasma concentration profile to that of green tea. Methods and Findings: Through in-vitro dissolution studies, we observed a significant release of EGCG in alkaline pH conditions, closely mimicking the intestinal absorption environment, supporting the effectiveness of the tablet formulation in enhancing EGCG absorption. The clinical aspect of our research involved a study of 22 healthy subjects to evaluate the relative bioavailability of EGCG, based on plasma concentration profiles (AUC) of EGCG from one tablet of TèPigal 300® in comparison with the consumption of one cup of green tea. Notably, in 10 healthy subjects EGCG was detectable in the bloodstream within 15 minutes, with increasing levels up to 60 minutes. This pattern suggests efficient absorption following EGCG release. Further comparison with the consumption of 1 cup of green tea in 12 healthy subjects highlighted the superior oral bioavailability of EGCG from TèPigal 300® tablets over tea beverage intake, quantifying this difference as one TèPigal 300® tablet being equivalent to consuming 21 cups of green tea. Conclusion: our study underlines TèPigal 300® advantage in providing a more efficient convenient form of EGCG consumption, leading to potentially greater health benefits. Our promising results open avenues for future research on improving EGCG bioavailability through new technologies and nutrients synergies.

Journal of Clinical Medical Research
Università degli Studi di Salerno
Openalex Percentile: Top 87%
Tea Polyphenols and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.